Liver Disorders Flashcards

1
Q

Physiologic liver functions

A
lipid, carb, protein metab
clotting factor production
detox
storage of vitamins and glycogen
bile processing and secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Liver composition and role

A

Composed of hepatocytes, bile ducts, blood vessels
Central organ of metabolic homeostasis
Large functional reserve and regenerative capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of chronic liver dz

A

Hep C, EtOH Induced, Non-EtOH fatty liver dz, Hep B

Also, blood flow abnormalities, usually INTRAHEPATIC lfow probs (from cirrhosis occlusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Grade and Stage

A
grade = amount of infl and injury
Stage = amount of fibrous tissue deposition (on liver biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Liver Failure (info/cause/3 types)

A

Caused by acute or chronic failure via cirrhosis
NEED TO HAVE 80-90% loss of function before you see sx
1) massive necrosis, 2) cirrhosis (scarred liver) 3) dysfunction +/- cirrhosis or necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Liver Failure (pres)

A

Ascites, jaundice, scleral icterus
Spider angioma, palmar erythema, gynecomastia
Coagulopathy, encephalopathy, renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cirrhosis (info/cause/pres)

A

Scarred liver, common end point to many chronic liver dz
Result of recurring death of hepatocytes and deposition of ECM
Pres with 1) PORTAL HTN (splenomegaly, eso varcies, ascties, periumbilical medusae, encephalotphay
2) JAUNDICE (bilirubin production > clearance)
3) CHOLESTASIS (impaired bile flow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cirrhosis (diagnx)

A

Diffuse fibrous septation that divides the liver parenchyma in NODULES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hepatitis (Acute)

Causes and Infl cell profiles

A

New onset (

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hepatitis (def)

A

Inflammatory dz of hepatocytes (liver) and characterized by presence of inflammatory cells in the tissue of the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hepatitis (Chronic)

Causes and accumulations

A

Sx dz for >6 mos
Common causes CHRONIC VIRAL (moslty C, B, D), autoimmune, drug injury
SPOTTY injury (looks less severe than acute)
Grade: amount of infl
Stage: amount of fibrosis
Cytoplasmic accumulations: fat (steatosis), bile (cholestasis), iron (hemosiderosis), Copper (Wilson), Viral (viral hepatitis GROUND GLASS HISTOL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
VIRAL HEPATITIS
Hep C (info)
A

Major cause of liver dz in US
Genetically unstable (many genotypes and subtypes)A
Anti-HCV Ab are made BUT are not neutralizing so NO VACCINE
Risks: IV drugs, multiple partners, surgery, needle injury, multiple HCV contacts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
VIRAL HEPATITIS
Hep C (pres/diagx/treat)
A

85% acute to chronic dz, often asymptomatic if acute
Diagnx: Lymphoid aggregates (see chronic hep)
Treat: GOAL: remain HCV RNA neg for 12 WEEKS AFTER STOPPING TX
Genotype 1: SVR 40-70% (PegIFN, Ribavarin, protease inhib)
Genotype 2 & 3: PegIFN, Ribavarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hepatotropic viruses

A

hepatocyte is primary target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SVR? (for Hep)

A

Sustained Virological Response = Cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
VIRAL HEPATITIS
Hep B (cause/diagnx/treat)
A

Major cause of liver dz WORLDWIDE
dsDNA virus (can integrate into genome)
Transmitted via blood, VACCINE EXISTS
Diagnx: GROUND GLASS HEPATOCYTES, SANDED NUCLEUS
Treat: IFN for 1 yr (flu-like side fx), nucleoside/tide (Tenofovir)
IF: HBsAg > 6 mos, HBV DNA > 10^5, persistent or intermittent high ALT and AST (cirrhosis)

17
Q
VIRAL HEPATITIS
Hep B (pres MARKERS)
A
Most ADULTS recover (5% progress to chronic) - more children do
HBsAg (surface antigen): ACTIVE INFX
HBsAb: IMMUNITY to HepB
HBcAb: ACTIVE or PRIOR infx
HbeAg: ('e' antigen) HIGH VIRAL LOAD
HBeAb: LOW VIRAL LOAD
HBV DNA: ACTIVE VIRAL REPLICATION
18
Q

VIRAL HEPATITIS

Hep D

A

cannot replicate, COMPLETELY DEPENDENT ON HEP B COINFECTION, potentiates effects of Hep B, parenteral transmission
Pres: increased risk of fulminant Hep, + activity and faster progress to end-stage liver dz
Diagnx: may show increased plasma cells

19
Q

VIRAL HEPATITIS

Hep A

A

Oral/fecal transmission (and bad strawberries)
VACCINE available
Does NOT progress to chronic
Diagnx: IgM Ab in serum

20
Q

VIRAL HEPATITIS

Hep E

A

Oral/fecal trans
HIGHER MORTALITY in PREGNANT WOMEN
Acute
Diagnx: Igm/IgG Ab in serum

21
Q

AUTOIMMUNE

Autoimmune Hep

A

Immune attack of hepatocytes, 78% women, usually with autoimmune dz
Pres: variable
Diagnx: serology: AutoAb (ANA, ASMA, Anti-LKMB) & elevated IgG but PLASMA CELL RICH
Treat: Immune suppression (steroids, Azathioprine), treat for a few years after normal to prevent relapse

22
Q

AUTOIMMUNE
Primary Biliary Cirrhosis
(info/pres)

A

Bad name: not necessarily cirrhosis
Immune attack of INTRAHEPATIC ONLY small caliber bile ducts
nearly ALWAYS middle aged women
Pres: INSIDIOUS ONSET WITH PRURITUS BEFORE JAUNDICE

23
Q

AUTOIMMUNE
Primary Biliary Cirrhosis (PBC)
(diagnx/treat)

A

Elevated ALP, IgM (GGT, bilirubin)
AMA in 90%
Granulotamous lympocytic cholangitis, florid duct lesion, eventual ductopenia
Treat: URSODEOXYCHOLIC ACID (aka ursodiol, slows prog)
Fair prognosis (25% with liver failure at 10 yrs)

24
Q

AUTOIMMUNE
Primary Sclerosing Cholangitis
(info/pres/treat)

A

Immune attack of INTRA- AND EXTRAHEPATIC bile ducts (usually larger caliber)
M>F, 70% have UC, increased risk for cholangiocarcinoma
Asymptomatic (elevated ALP) –> progresses to fatigure, pruritus, jaundice
Treat: no good tx, manage progression

25
Q

AUTOIMMUNE
Primary Sclerosing Cholangitis
(Diagnx)

A

Persistent ALP elevation and IgM
Diagnx with cholangiography (ALTERNATING BILIARY STRICTURES AND DILATION)
No specific serology
PERIDUCTAL “ONION SKIN” FIBROSIS –> progresses to fibrous obliteration of bile ducts

26
Q

DRUG INDUCED (general)

A

common cause with many patterns of injury
Intrinsic: all affected in dose related way
Idiosyncratic: only certain people have bad reaction
Treat: discontinue drug

27
Q

DRUG INDUCED

Acetaminophen

A

Intrinsic (all affected), often in suicide attempts
Major casue of ACUTE liver failure
Injury in ZONE 3 (cnetral vein), CONFLUENT CENTRILOBULAR COAGULATIVE NECROSIS
Treat: Remove drug (lavage, charcoal), N-acetylcysteine

28
Q

METABOLIC LIVER DZ
(here adults, but more common in kids)
EtOH related Steatohepatitis vs Non EtOH

A

EtOH: blocks lipid clearance (beta-oxidation of lipids into CO2 and ketones) and stimulates lipogenesis
Non-EtOH (NASH): assoc with metabolic syndrome (obesity, DM) fatty liver –> decreased lipolysis

29
Q

METABOLIC LIVER DZ

EtOH/non-EtOH Steatohepatitis (pres/diagnx/treat)

A

Steatosis = lipid production>clearance (may progress to steatohepatitis)
Diagnx: ballooned degeneration, PMN infiltrates pericentral/perilobar fibrosis
EtOH: Mallory Bodies (AST AT LEAST 2s ALT)
Treat: life modification

30
Q

METABOLIC LIVER DZ
Hereditary Hemochromatosis
(cause/pres)

A

Iron overload (genetic), AR, HFE mutation [C282Y and H63D], M>F
Pres: 44% with joint stiffness
Hyperpigmentation, Diabetes, Hypothyroidism
Hypogonadism, Cardiomyopathy, Cirrhosis

31
Q

METABOLIC LIVER DZ
Hereditary Hemochromatosis
(diagnx/treat)

A
Iron stain (prussian blue), Fe in HEPATOCYTES, NOT Kupffer cells (would be hemosiderosis)
HPE gene testing, + ferrtin, + transferrin sat., + Fe sat.
TREAT: Tx phlebotomy, endpoint: serum ferritin at 50ng/ml
- Fe intake, genetic counseling, if anemic: chelation
32
Q

METABOLIC LIVER DZ

Wilson Dz

A

Copper overload (genetic), AR, ATP7B mutation (transporter for bile excretion of Cu)
Pres: Liver dz and neuropsych dz
Diagnx: Copper stain (Rhodamine)
Treat: chelators (D-penacillinamince, tirentine, then transition to oral zinc

33
Q

METABOLIC LIVER DZ

Alpha-1-anti-trypsin

A

Dec produciton of A1AT (protease inhib), AR, PiZZ dz genotype (PiMZ heterozygote is normal)
Pres: assoc with emphysema (10% have liver dz)
Diagnx: PAS-positive, diastase resistant pink globules of A1AT in hepatocytes

34
Q
LIVER MASSES
Hepatocellular Carcinoma (malignant)
A

Most common malignant liver tumor
Almost always in pts with chronic liver dz (eg Hep B, C, EtOH), dismal long term survival
Diagnx: THICKENED HEPATIC PLATES (trabeculae), UNPAIRED ARTERIOLES (neovasculatization), ELEVATED AFP
Treat: resect/transplant and if not: trans-arterial chemoembolization

35
Q

LIVER MASSES

Malignant Cholangiocarcinoma

A

Neoplasm of bile ducts (intra- or extrahepatic), PSC is major risk factor, dismal long tern survival (25% at one year)
Diagnx: GLAND FORMING WITH DESMOPLASIA

36
Q

LIVER MASSES

Metastases

A

Common place for metastases, well circumscribed, most tumors in liver are metastatic of other cancers

37
Q

LIVER MASSES

Hemangioma (Benign)

A

MOST COMMON OF ALL HEPATIC TUMORS
F>M, 4:1
Pres: usually small and asymptomatic, vague RUQ pain, early satiety, nausea, vomiting
Diagnx: spongy appearance, dilated thin walled vascular spaces
Treat: resect for larger ones

38
Q

LIVER MASSES

Focal Nodular Hyperplasia (Benign)

A

F>M, 4:1, arise due to local vascular flow anomaly, hepatocyte mass
Pres: usually small and asymptomatic, vague RUQ pain, early satiety, nausea, vomiting
Looks cirrhotic but focal, CENTRAL STELLATE SCAR, ENLARGED ABNORMAL ARTERIOLES

39
Q
LIVER MASSES
Hepatocellular Adenoma (Benign)
A

Women of childbearing age, ORAL CONTRACEPTIVE USE, LOW RISK OF MALIGNANCY, no chronic liver dz
Pres: asymptomatic or RUQ pain, risk of rupture/hemorrhage into abd (if v large)
Diagnx: hepatocyte proliferation (looks like hepatocellular carcinoma)